≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Spina bifida

DOID EFO Endpoint Browser PheWeb

Q17_SPINA_BIFIDA

spina bifida: A congenital neural tube defect in which vertebrae are not fully formed. It results in the protrusion of the spinal cord through the opening of the vertebrae.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q05
  • Cause of death: ICD-10 — Q05

2 out of 7 registries used, show all original rules.

89

4. Check minimum number of events

None

89

5. Include endpoints

None

89

6. Filter based on genotype QC (FinnGen only)

79

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_NERVOUS_SYSTEM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q0

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1097 602 489
Only index persons 925 521 404
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.01
Only index persons 0.02 0.02 0.02
Median age at first event (years)
Whole population 12.19 14.94 8.44
Only index persons 15.83 18.69 12.14

-FinnGen-

Key figures

All Female Male
Number of individuals 79 53 26
Unadjusted period prevalence (%) 0.02 0.02 0.01
Median age at first event (years) 27.09 25.41 30.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
86
Matched controls
860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q05.2
ICD-10 Finland
Lumbar spina bifida with hydrocephalus
+∞
43.5
38
*
Q05.7
ICD-10 Finland
Lumbar spina bifida without hydrocephalus
+∞
36.0
32
*
Q05.9
ICD-10 Finland
Spina bifida, unspecified
+∞
32.3
29
*
7410D
ICD-9 Finland
Spina bifida, With hydrocephalus[SPINA BIFIDA APERTA CUM HYDROCEPHALO REG LUMBALIS]
+∞
28.8
26
*
XKC03
NOMESCO Finland
Water cystometry
79.3
28.5
31
6
UKC02
NOMESCO Finland
Cystoscopy
12.4
27.7
35
45
204
Kela drug reimbursment
Leukemia lymphatica
40.9
24.3
30
11
G04AC01, ,
ATC
37.5
23.8
30
12
L89
ICD-10 Finland
Decubitus ulcer and pressure area
+∞
22.9
21
*
J01EA01
ATC
trimethoprim; systemic
8.2
21.9
52
135
G04BD04
ATC
oxybutynin; oral, transdermal
28.9
20.8
28
14
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
+∞
20.6
19
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
8.5
20.6
36
67
J01XE01
ATC
nitrofurantoin; oral
36.2
19.1
24
9
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
56.1
15.8
18
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
15.7
15.6
26
23
Q05.0
ICD-10 Finland
Cervical spina bifida with hydrocephalus
+∞
15.0
14
*
7419D
ICD-9 Finland
Spina bifida, Without mention of hydrocephalus[SPINA BIFIDA APERTA SINE HYDROCEPHALO REG LUMBALIS]
+∞
15.0
14
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
52.1
14.7
17
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
29.9
14.5
19
8
R15
ICD-10 Finland
Faecal incontinence
31.9
14.0
18
7
Q05.8
ICD-10 Finland
Sacral spina bifida without hydrocephalus
+∞
13.9
13
*
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
165.0
13.9
14
*
J01MA12
ATC
levofloxacin; systemic
6.3
13.6
29
64
G04BD07
ATC
tolterodine; oral
21.7
13.2
19
11
XKD00
NOMESCO Finland
Uroflowmetry
7.8
13.2
21
34
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
22.3
12.7
18
10
S97
ICPC
Chronic ulcer skin
14.9
12.1
20
17
J01MA02
ATC
ciprofloxacin; systemic
4.8
12.0
49
185
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
11.7
11
*
Q05.3
ICD-10 Finland
Sacral spina bifida with hydrocephalus
+∞
11.7
11
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
5.1
11.2
31
85
1530
FHL
Urethrocystoscopy
32.9
11.1
14
5
N39.4
ICD-10 Finland
Other specified urinary incontinence
13.2
11.0
19
18
74101
ICD-8 Finland
Spina bifida, Cum hydrocephalo, non cute tecta
+∞
10.6
10
*
Q06.8
ICD-10 Finland
Other specified congenital malformations of spinal cord
+∞
10.6
10
*
74190
ICD-8 Finland
Spina bifida, Hydrocephalo non indicato, cute tecta
+∞
10.6
10
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
10.6
10
*
G04BD08
ATC
solifenacin; oral
12.3
10.1
18
18
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
9.5
9
*
9165
FHL
Removal of osteosynthesis material
55.9
8.9
10
*
SPAT1262
SPAT
Handing over of treatment supplies
4.9
8.6
23
60
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
99.4
8.6
9
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
5.7
8.6
18
38
74199
ICD-8 Finland
Spina bifida, Without mention of hydrocephalus
+∞
8.5
8
*
KDV20
NOMESCO Finland
Submucous urethral injection
+∞
8.5
8
*
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
+∞
8.5
8
*
74191
ICD-8 Finland
Spina bifida, Hydrocephalo non indicato, non ente tecta
+∞
8.5
8
*
74100
ICD-8 Finland
Spina bifida, Cum hydrocephalo, cute tecta
+∞
8.5
8
*
SPAT1229
SPAT
Assessment of need for aid
13.7
8.4
14
12
A46
ICD-10 Finland
Erysipelas
4.8
8.1
22
58
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
49.7
7.9
9
*
A28
ICPC
Limited function/disability NOS
4.6
7.8
22
60
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
15.2
7.6
12
9
2133
FHL
Suntin revisio
+∞
7.4
7
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
5.2
7.3
17
39
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
22.3
7.3
10
5
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.9
7.2
18
44
J01MA06
ATC
norfloxacin; oral
4.7
7.2
19
49
X59
ICD-10 Finland
Exposure to unspecified factor
3.7
7.0
29
104
R33
ICD-10 Finland
Retention of urine
9.1
6.9
14
18
ZXE10
NOMESCO Finland
More than one and less than three hours
3.4
6.9
38
164
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
43.6
6.9
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
3.3
6.8
42
194
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
11.4
6.8
12
12
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
6.0
6.7
18
36
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
3.4
6.6
33
133
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.4
6.6
19
52
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
6.8
6.5
16
28
G91.1
ICD-10 Finland
Obstructive hydrocephalus
75.2
6.5
7
*
Q66.0
ICD-10 Finland
Talipes equinovarus
75.2
6.5
7
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.6
6.5
27
97
NE1AA
NOMESCO Finland
Pelvis X-ray examination
8.8
6.4
13
17
A06AC01
ATC
ispaghula (psylla seeds); oral
3.4
6.3
30
117
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
6.3
6
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
6.3
6
*
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
+∞
6.3
6
*
S18
ICPC
Laceration/cut
3.1
6.2
45
225
U07
ICPC
Urine symptom/complaint other
6.3
6.2
16
30
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
4.5
6.2
17
45
R51.80
ICD-10 Finland
Headache
3.3
6.1
30
119
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.6
6.0
16
41
K59.09
ICD-10 Finland
Constipation, unspecified
7.8
6.0
13
19

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
57
197
6.61
16.82
8.7
2.8
—
—
—
0
0
39
146
4.06
9.20
4.6
2.5
5.35
12.78
e6/l
0.76
33
136
29
90
4.35
8.79
4.9
1.4
—
—
—
0
0
44
184
3.85
8.76
6.9
3.0
0.29
0.45
e6/l
0.40
37
137
41
168
3.75
8.34
8.0
4.2
—
—
—
0
0
47
219
3.53
7.70
7.9
3.2
21.63
46.93
e6/l
0.88
40
171
23
73
3.94
6.60
4.3
12.5
105.04
103.88
mmol/l
0.49
23
73
58
328
3.36
6.60
6.9
3.2
6.60
6.24
ph
1.71
29
193
63
385
3.38
6.09
9.3
3.6
0.07
0.00
estimate
0.47
14
83
22
72
3.76
6.01
3.3
6.6
7.37
7.38
ph
0.62
15
45
63
390
3.30
5.86
10.0
3.6
0.00
0.00
estimate
-0.00
14
76
62
384
3.20
5.69
10.1
3.6
0.00
0.00
estimate
-0.00
14
81
48
263
2.87
5.43
9.8
4.0
210.82
37.42
e6/l
0.68
39
182
65
444
2.90
4.45
5.9
11.0
4.47
4.03
e9/l
0.81
57
397
7
6
12.54
4.35
3.0
5.0
—
—
—
0
0
18
65
3.24
4.16
2.6
6.7
4.31
4.57
kpa
0.33
18
65
15
49
3.50
4.03
3.5
6.5
23.82
24.40
mmol/l
0.31
15
49
51
320
2.46
3.99
9.1
8.7
1.21
1.22
mmol/l
0.43
43
274
43
256
2.36
3.71
2.7
1.9
93.50
95.33
pmol/l
0.11
25
129
23
102
2.71
3.70
4.4
1.7
—
—
—
0
0
60
417
2.45
3.58
9.7
5.5
6.35
6.26
mmol/l
0.08
60
389
31
162
2.43
3.56
1.5
2.4
0.67
0.85
mg/l
0.48
26
126
17
67
2.92
3.37
8.0
11.5
—
—
—
0
0
37
214
2.28
3.34
4.7
6.9
—
—
—
0
0
38
223
2.26
3.31
3.0
2.9
2.34
2.35
mmol/l
0.15
33
210
43
266
2.23
3.29
23.2
9.9
1.28
1.16
inr
0.53
37
224
51
349
2.13
2.92
5.3
6.6
9.03
11.81
umol/l
1.27
44
335
39
241
2.13
2.91
5.4
7.5
—
—
—
0
0
38
234
2.12
2.85
3.2
2.1
—
—
—
0
0
46
305
2.09
2.83
10.0
3.2
0.09
0.01
estimate
0.38
11
72
56
403
2.12
2.74
5.2
6.9
0.54
0.53
e9/l
0.09
45
358
7
15
4.98
2.65
3.1
3.3
—
—
—
0
0
56
406
2.09
2.65
5.2
6.8
0.04
0.04
e9/l
0.23
45
360
35
215
2.06
2.60
11.1
3.6
0.00
0.00
estimate
-0.00
13
79
7
16
4.66
2.53
1.9
2.1
—
—
—
0
0
56
418
1.97
2.30
5.2
6.9
1.80
2.06
e9/l
0.90
46
382
56
425
1.91
2.11
5.3
7.1
0.20
0.19
e9/l
0.27
46
382
11
45
2.66
2.02
23.5
5.3
7.41
7.41
ph
0.03
11
39
8
27
3.16
1.99
3.1
6.0
37.06
37.01
°c
—
8
27
0
53
0.00
1.95
0.0
1.5
—
279.72
—
0
28
32
208
1.86
1.93
9.5
2.9
1.02
1.02
kg/l
0.00
18
132
33
220
1.81
1.82
1.1
1.6
2.00
2.08
g/l
0.17
19
149
5
13
4.01
1.74
19.6
8.2
—
—
—
0
0
8
31
2.74
1.71
1.4
2.1
—
—
—
0
0
15
78
2.12
1.66
1.0
1.2
—
—
—
0
0
8
32
2.65
1.64
7.0
6.2
24.90
24.28
mmol/l
—
8
32
5
14
3.72
1.64
2.4
2.2
—
—
—
0
0
49
375
1.71
1.63
5.6
6.9
0.67
0.71
%
0.19
44
359
47
356
1.71
1.62
3.6
2.6
—
—
estimate
—
0
0
50
386
1.71
1.60
5.5
6.9
25.43
29.43
%
2.14
45
374
32
223
1.69
1.47
8.6
2.8
0.00
0.00
estimate
-0.00
11
63
48
374
1.64
1.42
5.7
6.9
2.93
2.94
%
0.01
43
359
48
376
1.63
1.38
5.7
7.0
8.33
8.20
%
0.15
43
362
27
183
1.69
1.36
8.0
4.3
7.39
7.40
ph
0.30
20
138
45
348
1.61
1.36
17.9
11.2
0.00
0.00
e9/l
0.50
37
282
32
228
1.64
1.33
1.1
1.4
0.59
2.09
u/ml
—
7
56
8
36
2.34
1.28
7.1
5.9
—
—
—
0
0
12
64
2.02
1.25
9.8
11.6
7.44
7.43
ph
—
6
36
8
37
2.28
1.25
1.9
6.0
0.59
0.60
%
—
8
37
8
38
2.22
1.22
1.1
4.4
19.88
20.00
s
—
8
32
0
29
0.00
1.00
0.0
1.1
—
0.16
—
0
14
0
30
0.00
0.99
0.0
1.1
—
2.77
—
0
18
12
70
1.83
0.98
1.0
1.4
—
—
—
0
0
11
63
1.86
0.95
1.3
1.7
—
—
—
0
0
11
63
1.86
0.95
9.7
11.4
1.23
1.33
mmol/l
0.13
11
63
14
87
1.73
0.94
1.5
1.2
—
—
—
0
0
6
28
2.23
0.93
4.2
4.6
—
—
—
0
0
28
209
1.50
0.92
3.2
5.1
—
—
—
0
0
10
57
1.85
0.88
12.0
12.6
25.89
25.89
mmol/l
—
10
57
8
45
1.86
0.87
1.1
1.9
—
—
—
0
0
6
32
1.94
0.83
1.2
1.1
—
—
—
0
0
0
24
0.00
0.80
0.0
1.0
—
9.08
—
0
13
0
24
0.00
0.80
0.0
1.0
—
13.68
—
0
11
0
26
0.00
0.80
0.0
1.1
—
4.57
—
0
16
11
67
1.74
0.79
1.3
1.6
—
—
—
0
0
11
67
1.74
0.79
1.3
1.6
—
—
—
0
0
11
169
0.60
0.79
1.2
1.7
—
—
—
0
0
11
68
1.71
0.76
1.3
1.7
—
—
—
0
0
24
308
0.69
0.75
3.3
2.7
—
—
—
0
0
7
39
1.86
0.74
14.3
14.2
0.71
0.69
%
—
7
39
7
39
1.86
0.74
14.3
14.4
95.19
93.76
%
—
7
39
79
742
1.79
0.74
32.6
13.5
27.15
19.47
mg/l
1.53
72
588
22
163
1.47
0.74
3.6
4.0
3.36
8.55
mg/mmol
1.04
16
102
7
40
1.81
0.73
14.3
13.9
1.46
1.46
%
—
7
40
6
101
0.56
0.67
1.3
1.3
—
—
—
0
0
21
268
0.71
0.62
1.7
2.1
—
—
—
0
0
8
53
1.56
0.60
1.4
1.8
—
—
—
0
0
19
143
1.42
0.59
1.1
1.4
3.67
4.94
u/ml
—
7
56
9
62
1.50
0.55
14.6
3.2
—
—
—
0
0
32
267
1.32
0.53
1.9
2.1
—
—
—
0
0
71
662
1.42
0.53
29.8
16.5
13.57
13.34
%
0.79
71
656
24
193
1.34
0.51
3.7
3.5
—
—
—
0
0
7
46
1.57
0.50
21.3
5.8
1.21
1.23
mmol/l
—
7
41
12
161
0.70
0.46
1.9
1.7
—
—
—
0
0
6
94
0.61
0.45
1.5
1.2
—
—
—
0
0
5
32
1.60
0.43
1.2
3.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
0.66
—
0
7
0
17
0.00
0.41
0.0
1.1
—
0.25
—
0
8
5
35
1.45
0.40
19.2
14.6
26.60
25.37
mmol/l
—
5
35
9
68
1.36
0.39
1.3
1.7
—
—
—
0
0
9
69
1.34
0.39
3.0
4.4
—
0.06
—
0
16
81
781
1.64
0.37
29.0
14.9
67.10
70.97
umol/l
0.21
81
773
28
245
1.21
0.30
4.8
3.4
22.65
20.21
ng/l
0.09
20
131
66
690
0.81
0.28
3.8
4.1
1.33
1.44
mmol/l
1.33
61
658
19
162
1.22
0.25
3.6
3.3
19.09
69.01
mg/l
1.44
14
109
5
38
1.33
0.23
1.0
1.4
0.29
0.22
g/l
—
5
38
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
13.3
—
796.20
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
111.54
—
0
10
0
12
0.00
0.21
0.0
2.8
—
19.33
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
14
119
1.21
0.19
1.4
2.2
123.25
127.06
ug/g
—
8
91
7
62
1.14
0.18
1.0
1.1
—
—
—
0
0
19
213
0.86
0.17
1.8
1.8
—
—
—
0
0
29
266
1.14
0.17
1.2
1.5
—
—
—
0
0
79
771
1.30
0.15
23.7
11.6
—
—
—
0
0
18
161
1.15
0.14
1.2
1.3
19.77
29.69
iu/ml
—
7
46
17
152
1.15
0.13
1.6
1.6
—
—
—
0
0
81
817
0.85
0.10
38.5
21.1
39.79
40.78
%
0.84
81
812
68
692
0.92
0.06
4.0
4.2
4.47
4.71
mmol/l
1.39
63
662
0
6
0.00
0.00
0.0
1.8
—
32.17
—
0
6
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
12.2
—
8.53
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
37.7
—
5.58
—
0
6
0
8
0.00
0.00
0.0
6.3
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
23.50
—
0
6
0
6
0.00
0.00
0.0
1.5
—
7.65
—
0
6
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
1809.17
—
0
6
0
8
0.00
0.00
0.0
2.1
—
65.75
—
0
8
0
8
0.00
0.00
0.0
3.1
—
67.75
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
51.62
—
0
5
0
9
0.00
-0.00
0.0
2.0
—
41.32
—
0
9
0
5
0.00
-0.00
0.0
1.6
—
64.00
—
0
5
0
7
0.00
-0.00
0.0
1.4
—
0.64
—
0
7
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.4
—
17.86
—
0
7
0
5
0.00
-0.00
0.0
3.4
—
—
—
0
0
8
83
0.96
-0.00
1.5
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
5.1
—
6.14
—
0
7
0
7
0.00
-0.00
0.0
1.6
—
297.14
—
0
7
8
85
0.94
-0.00
1.5
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
40.40
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
5.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
11.0
—
0.64
—
0
9
0
5
0.00
-0.00
0.0
7.2
—
—
—
0
0
8
83
0.96
-0.00
1.3
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
54
0.92
-0.00
2.8
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
0.56
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
6.70
—
0
7
0
9
0.00
-0.00
0.0
1.2
—
224.00
—
0
9

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_SPINA_BIFIDA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_SPINA_BIFIDA.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: Q17_SPINA_BIFIDA – Spina bifida

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data